Payment overview · 2025
General Payments
$284.00
14 reported records · 9 companies
Healthcare provider profile · identity verified
William Alan Morton, M.D.
Allopathic & Osteopathic Physicians|General Practice · WAYCROSS, GA · NPI 1881614584
Verified facts
What the public records show
CMS Open Payments records show William Alan Morton, M.D. received $284.00 in general payments during 2025 across 14 reported records.
Boston Scientific Corporation accounted for 21.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 11 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga, Ozempic.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 72 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 235 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 50 claims for Synthroid by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 63 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 346 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 33 claims for Lokelma by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 91 claims for Symbicort by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 276 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $61.47 | 21.6% | 2 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $53.65 | 18.9% | 3 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $36.19 | 12.7% | 2 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $35.24 | 12.4% | 2 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $29.48 | 10.4% | 1 | 2025 |
| SANOFI PASTEUR INC. | Unresolved — no canonical attribution shown | $20.20 | 7.1% | 1 | 2025 |
| Ardelyx, Inc. | Unresolved — no canonical attribution shown | $16.96 | 6.0% | 1 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $16.51 | 5.8% | 1 | 2025 |
| Antares Pharma, Inc. | Unresolved — no canonical attribution shown | $14.30 | 5.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $284.00 | 14 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| General - Pain Management Normalized: general pain management |
Device | Boston Scientific Corporation | $61.47 | 2 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $36.37 | 2 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $36.19 | 2 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $35.24 | 2 | 2025 |
Source payment records
|
|||||
| FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE Normalized: flublok quadrivalent northern hemisphere |
Biological | SANOFI PASTEUR INC. | $20.20 | 1 | 2025 |
Source payment records
|
|||||
| FLUZONE HIGH-DOSE Normalized: fluzone high dose |
Biological | SANOFI PASTEUR INC. | $20.20 | 1 | 2025 |
Source payment records
|
|||||
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $17.28 | 1 | 2025 |
Source payment records
|
|||||
| IBSRELA Normalized: ibsrela |
Drug | Ardelyx, Inc. | $16.96 | 1 | 2025 |
Source payment records
|
|||||
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $16.51 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $14.67 | 1 | 2025 |
Source payment records
|
|||||
| XYOSTED Normalized: xyosted |
Drug | Antares Pharma, Inc. | $14.30 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 346 | exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 276 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
72 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
235 | 46 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
50 | 13 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
63 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
346 | 48 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | LOKELMA open payments reported associated product |
CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624 |
Lokelma · 2024 Exact normalized brand match · 1 Part D row |
33 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
91 | 18 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
276 | 55 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 3402 | 295 |
| Atorvastatin Calcium | Atorvastatin Calcium | 3126 | 428 |
| Amlodipine Besylate | Amlodipine Besylate | 2876 | 287 |
| Levothyroxine Sodium | Levothyroxine Sodium | 2652 | 262 |
| Potassium Chloride | Potassium Chloride | 2630 | 213 |
| Furosemide | Furosemide | 2450 | 220 |
| Eliquis | Apixaban | 2115 | 158 |
| Pantoprazole Sodium | Pantoprazole Sodium | 2089 | 279 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 2024 | 293 |
| Clopidogrel | Clopidogrel Bisulfate | 1678 | 157 |
| Carvedilol | Carvedilol | 1629 | 199 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 1584 | 122 |
| Losartan Potassium | Losartan Potassium | 1551 | 201 |
| Lisinopril | Lisinopril | 1503 | 188 |
| Famotidine | Famotidine | 1448 | 117 |
| Sertraline Hcl | Sertraline Hcl | 1331 | 112 |
| Omeprazole | Omeprazole | 1236 | 160 |
| Donepezil Hcl | Donepezil Hcl | 1218 | 63 |
| Metformin Hcl | Metformin Hcl | 1203 | 164 |
| Memantine Hcl | Memantine Hcl | 1125 | 59 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1119 | 129 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1090 | 119 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 1049 | 134 |
| Quetiapine Fumarate | Quetiapine Fumarate | 960 | 66 |
| Hydrochlorothiazide | Hydrochlorothiazide | 895 | 111 |
| Trazodone Hcl | Trazodone Hcl | 891 | 88 |
| Citalopram Hbr | Citalopram Hydrobromide | 865 | 85 |
| Oxycodone Hcl | Oxycodone Hcl | 861 | 99 |
| Meloxicam | Meloxicam | 825 | 135 |
| Metoprolol Succinate | Metoprolol Succinate | 816 | 113 |
| Spironolactone | Spironolactone | 794 | 76 |
| Escitalopram Oxalate | Escitalopram Oxalate | 782 | 64 |
| Allopurinol | Allopurinol | 778 | 49 |
| Tramadol Hcl | Tramadol Hcl | 746 | 154 |
| Alprazolam | Alprazolam | 735 | 114 |
| Duloxetine Hcl | Duloxetine Hcl | 711 | 73 |
| Simvastatin | Simvastatin | 701 | 114 |
| Montelukast Sodium | Montelukast Sodium | 684 | 105 |
| Divalproex Sodium | Divalproex Sodium | 670 | 32 |
| Lorazepam | Lorazepam | 667 | 134 |
| Hydralazine Hcl | Hydralazine Hcl | 658 | 49 |
| Levetiracetam | Levetiracetam | 569 | 45 |
| Fluoxetine Hcl | Fluoxetine Hcl | 554 | 38 |
| Ropinirole Hcl | Ropinirole Hcl | 547 | 51 |
| Myrbetriq | Mirabegron | 535 | 34 |
| Sucralfate | Sucralfate | 512 | 42 |
| Mirtazapine | Mirtazapine | 498 | 47 |
| Zolpidem Tartrate | Zolpidem Tartrate | 492 | 75 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 476 | 136 |
| Olanzapine | Olanzapine | 459 | 33 |
| Buspirone Hcl | Buspirone Hcl | 436 | 44 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 431 | 61 |
| Rivastigmine | Rivastigmine Tartrate | 430 | 19 |
| Finasteride | Finasteride | 419 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 413 | 113 |
| Ondansetron Hcl | Ondansetron Hcl | 406 | 110 |
| Pravastatin Sodium | Pravastatin Sodium | 397 | 44 |
| Risperidone | Risperidone | 375 | 22 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 370 | 20 |
| Jardiance | Empagliflozin | 365 | 49 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 349 | 73 |
| Farxiga | Dapagliflozin Propanediol | 346 | 48 |
| Tizanidine Hcl | Tizanidine Hcl | 334 | 66 |
| Metolazone | Metolazone | 322 | 14 |
| Metoclopramide Hcl | Metoclopramide Hcl | 321 | 22 |
| Pregabalin | Pregabalin | 319 | 58 |
| Topiramate | Topiramate | 315 | 22 |
| Amiodarone Hcl | Amiodarone Hcl | 281 | 33 |
| Ozempic | Semaglutide | 276 | 55 |
| Glimepiride | Glimepiride | 267 | 34 |
| Atenolol | Atenolol | 257 | 33 |
| Nifedipine Er | Nifedipine | 246 | 22 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 241 | 17 |
| Paroxetine Hcl | Paroxetine Hcl | 240 | 18 |
| Linzess | Linaclotide | 235 | 46 |
| Xarelto | Rivaroxaban | 235 | 27 |
| Glipizide Er | Glipizide | 234 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 215 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 214 | 25 |
| Memantine Hcl Er | Memantine Hcl | 214 | suppressed |
| Januvia | Sitagliptin Phosphate | 207 | 26 |
| Clonazepam | Clonazepam | 201 | 38 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 201 | 29 |
| Fenofibrate | Fenofibrate | 198 | 20 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 194 | 21 |
| Cephalexin | Cephalexin | 178 | 75 |
| Mounjaro | Tirzepatide | 178 | 42 |
| Temazepam | Temazepam | 178 | 31 |
| Ezetimibe | Ezetimibe | 177 | 24 |
| Primidone | Primidone | 177 | 11 |
| Alendronate Sodium | Alendronate Sodium | 173 | 25 |
| Fluconazole | Fluconazole | 173 | 72 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 173 | 20 |
| Humalog Kwikpen U-100 | Insulin Lispro | 170 | 39 |
| Diltiazem Hcl | Diltiazem Hcl | 159 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 157 | 12 |
| Novolog Flexpen | Insulin Aspart | 155 | 33 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 153 | 36 |
| Glipizide | Glipizide | 150 | 19 |
| Labetalol Hcl | Labetalol Hcl | 148 | suppressed |
| Bumetanide | Bumetanide | 147 | 22 |
| Celecoxib | Celecoxib | 147 | 33 |
| Promethazine Hcl | Promethazine Hcl | 142 | 39 |
| Diazepam | Diazepam | 139 | 29 |
| Azithromycin | Azithromycin | 138 | 114 |
| Benztropine Mesylate | Benztropine Mesylate | 136 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 136 | 25 |
| Cefdinir | Cefdinir | 131 | 117 |
| Methadone Hcl | Methadone Hcl | 128 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 125 | 37 |
| Latanoprost | Latanoprost | 123 | 26 |
| Prednisone | Prednisone | 122 | 55 |
| Propranolol Hcl | Propranolol Hcl | 122 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 120 | 28 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 120 | 13 |
| Tresiba Flextouch U-100 | Insulin Degludec | 118 | 30 |
| Aripiprazole | Aripiprazole | 111 | 14 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 110 | 34 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 109 | 27 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 108 | 27 |
| Oxybutynin Chloride | Oxybutynin Chloride | 107 | 18 |
| Meclizine Hcl | Meclizine Hcl | 106 | 32 |
| Solifenacin Succinate | Solifenacin Succinate | 106 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 105 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 105 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 103 | 41 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 101 | 41 |
| Midodrine Hcl | Midodrine Hcl | 100 | 15 |
| Ventolin Hfa | Albuterol Sulfate | 99 | 26 |
| Bupropion Xl | Bupropion Hcl | 97 | 14 |
| Rivastigmine | Rivastigmine | 96 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 95 | 47 |
| Doxycycline Hyclate | Doxycycline Hyclate | 95 | 70 |
| Methenamine Mandelate | Methenamine Mandelate | 95 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 95 | 27 |
| Lovastatin | Lovastatin | 94 | 12 |
| Ondansetron Odt | Ondansetron | 94 | 55 |
| Terazosin Hcl | Terazosin Hcl | 94 | 13 |
| Zonisamide | Zonisamide | 94 | suppressed |
| Carisoprodol | Carisoprodol | 93 | 12 |
| Prazosin Hcl | Prazosin Hcl | 93 | suppressed |
| Ibuprofen | Ibuprofen | 91 | 20 |
| Symbicort | Budesonide/Formoterol Fumarate | 91 | 18 |
| Amitriptyline Hcl | Amitriptyline Hcl | 90 | 21 |
| Nystatin | Nystatin | 89 | 55 |
| Sevelamer Carbonate | Sevelamer Carbonate | 89 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 88 | 66 |
| Fenofibrate | Fenofibrate Nanocrystallized | 88 | 22 |
| Megestrol Acetate | Megestrol Acetate | 86 | 27 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 86 | 16 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 85 | suppressed |
| Entresto | Sacubitril/Valsartan | 84 | 15 |
| Methocarbamol | Methocarbamol | 84 | 18 |
| Doxazosin Mesylate | Doxazosin Mesylate | 83 | suppressed |
| Acyclovir | Acyclovir | 81 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 81 | 11 |
| Metformin Hcl Er | Metformin Hcl | 81 | 11 |
| Methenamine Hippurate | Methenamine Hippurate | 81 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 80 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 79 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 78 | 48 |
| Digoxin | Digoxin | 77 | suppressed |
| Estradiol | Estradiol | 77 | 13 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 76 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 76 | suppressed |
| Methylprednisolone | Methylprednisolone | 76 | 71 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 75 | 14 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 74 | suppressed |
| Creon | Lipase/Protease/Amylase | 72 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 72 | 50 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 71 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 71 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 70 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 68 | 16 |
| Baclofen | Baclofen | 67 | 15 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 66 | 15 |
| Bethanechol Chloride | Bethanechol Chloride | 64 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 64 | suppressed |
| Brilinta | Ticagrelor | 63 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 63 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 63 | 17 |
| Ingrezza | Valbenazine Tosylate | 63 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 62 | 14 |
| Flecainide Acetate | Flecainide Acetate | 62 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 62 | 14 |
| Valsartan | Valsartan | 62 | 11 |
| Letrozole | Letrozole | 60 | suppressed |
| Mupirocin | Mupirocin | 60 | 41 |
| Multaq | Dronedarone Hcl | 59 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 59 | 12 |
| Ceftriaxone | Ceftriaxone Sodium | 57 | 33 |
| Lamotrigine | Lamotrigine | 57 | 13 |
| Calcium Acetate | Calcium Acetate | 56 | suppressed |
| Enulose | Lactulose | 56 | 15 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 55 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 55 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 55 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 53 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 53 | suppressed |
| Otezla | Apremilast | 53 | suppressed |
| Pimozide | Pimozide | 53 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 52 | 52 |
| Azelastine Hcl | Azelastine Hcl | 52 | 20 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 52 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 52 | suppressed |
| Relistor | Methylnaltrexone Bromide | 52 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 51 | 44 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 50 | suppressed |
| Synthroid | Levothyroxine Sodium | 50 | 13 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 47 | 32 |
| Levofloxacin | Levofloxacin | 47 | 34 |
| Lidocaine | Lidocaine | 47 | suppressed |
| Sotalol | Sotalol Hcl | 47 | suppressed |
| Amoxicillin | Amoxicillin | 46 | 36 |
| Fentanyl | Fentanyl | 46 | suppressed |
| Nitroglycerin | Nitroglycerin | 46 | 14 |
| Enalapril Maleate | Enalapril Maleate | 45 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 45 | suppressed |
| Chlorthalidone | Chlorthalidone | 44 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 44 | suppressed |
| Entacapone | Entacapone | 44 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 44 | suppressed |
| Verapamil Er | Verapamil Hcl | 44 | suppressed |
| Irbesartan | Irbesartan | 43 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 42 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 40 | suppressed |
| Febuxostat | Febuxostat | 40 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 40 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 39 | suppressed |
| Lansoprazole | Lansoprazole | 39 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 39 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 39 | 28 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 38 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 37 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 37 | 25 |
| Nystop | Nystatin | 37 | 22 |
| Scopolamine | Scopolamine | 37 | suppressed |
| Timolol Maleate | Timolol Maleate | 37 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 36 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 36 | suppressed |
| Trulicity | Dulaglutide | 36 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 36 | suppressed |
| Exelon | Rivastigmine | 35 | suppressed |
| Ketoconazole | Ketoconazole | 35 | 13 |
| Phenobarbital | Phenobarbital | 35 | suppressed |
| Rexulti | Brexpiprazole | 35 | suppressed |
| Colchicine | Colchicine | 34 | 14 |
| Lokelma | Sodium Zirconium Cyclosilicate | 33 | suppressed |
| Mirabegron Er | Mirabegron | 33 | suppressed |
| Phenytoin | Phenytoin | 33 | suppressed |
| Topiramate Er | Topiramate | 32 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 31 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 31 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 31 | suppressed |
| Clonidine | Clonidine | 30 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 30 | suppressed |
| Hydrocortisone | Hydrocortisone | 30 | 15 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 30 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 29 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 28 | 25 |
| Eszopiclone | Eszopiclone | 28 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 28 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 27 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 27 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 26 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 26 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 26 | 26 |
| Atrovent Hfa | Ipratropium Bromide | 25 | suppressed |
| Glyburide | Glyburide | 25 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 25 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 25 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 24 | 15 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 24 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 24 | suppressed |
| Naproxen | Naproxen | 24 | 14 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 24 | 17 |
| Tolvaptan | Tolvaptan | 24 | suppressed |
| Erythromycin | Erythromycin Base | 23 | 14 |
| Gentamicin Sulfate | Gentamicin Sulfate | 23 | 18 |
| Cilostazol | Cilostazol | 22 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 21 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 21 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 21 | 15 |
| Clobetasol Propionate | Clobetasol Propionate | 20 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 20 | suppressed |
| Dulera | Mometasone/Formoterol | 20 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 20 | suppressed |
| Lactulose | Lactulose | 20 | 12 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 20 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 19 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 19 | 19 |
| Retacrit | Epoetin Alfa-Epbx | 19 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 18 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 18 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 18 | suppressed |
| Movantik | Naloxegol Oxalate | 18 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 18 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 18 | suppressed |
| Tradjenta | Linagliptin | 18 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Folic Acid | Folic Acid | 17 | suppressed |
| Klor-Con M20 | Potassium Chloride | 17 | suppressed |
| Leflunomide | Leflunomide | 17 | suppressed |
| Ranolazine Er | Ranolazine | 17 | suppressed |
| Sotalol Af | Sotalol Hcl | 17 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 17 | suppressed |
| Veozah | Fezolinetant | 17 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 16 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 16 | suppressed |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 16 | 11 |
| Enoxaparin Sodium | Enoxaparin Sodium | 16 | suppressed |
| Imipenem-Cilastatin Sodium | Imipenem/Cilastatin Sodium | 16 | suppressed |
| Insulin Lispro | Insulin Lispro | 16 | suppressed |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Haloperidol | Haloperidol | 15 | suppressed |
| Humalog | Insulin Lispro | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 15 | suppressed |
| Budesonide | Budesonide | 14 | suppressed |
| Daptomycin | Daptomycin | 14 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 14 | suppressed |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Novolog | Insulin Aspart | 14 | suppressed |
| Rifampin | Rifampin | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Dexamethasone | Dexamethasone | 13 | 12 |
| Jentadueto | Linagliptin/Metformin Hcl | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 13 | suppressed |
| Niacin Er | Niacin | 13 | suppressed |
| Praluent Pen | Alirocumab | 13 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Advocate Syringes | Syringe-Needle,insulin,0.5 Ml | 12 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 12 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 12 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 12 | suppressed |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 12 | suppressed |
| Propafenone Hcl Er | Propafenone Hcl | 12 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 12 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Desoximetasone | Desoximetasone | 11 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Nyamyc | Nystatin | 11 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Trulance | Plecanatide | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $284.00 · 14 records | Boston Scientific Corporation | AIRSUPRA, CAPLYTA, CAPVAXIVE, FARXIGA, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE HIGH-DOSE, General - Pain Management, IBSRELA, Ozempic, Rybelsus, XYOSTED | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Farxiga play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error